Home › Employers › Sigmapharm Laboratories, LLC
Sigmapharm Laboratories, LLC: H-1B salaries and sponsorship
Sigmapharm Laboratories, LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $105,000.
Does Sigmapharm Laboratories, LLC sponsor H-1B visas?
Sigmapharm Laboratories, LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 2, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Sr. Chemist | 1 | $103,000 |
| Manager, Analytical Development (Chemist) | 1 | $130,000 |
| Senior Chemist II | 1 | $105,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $103,000 |
| FY2025 | 1 | $130,000 |
| FY2026 | 1 | $105,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Senior Chemist II | $105,000–$115,000 Level III | Bensalem, PA | Mar 2, 2026 | Sep 1, 2026 | Certified |
| Manager, Analytical Development (Chemist) | $130,000–$150,000 Level IV | Bensalem, PA | Apr 7, 2025 | Aug 30, 2025 | Certified |
| Sr. Chemist | $103,000–$113,000 Level III | Bensalem, PA | Mar 6, 2023 | Sep 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).